Mario Masellis
@MarioMasellis
Professor of Medicine/Neurology, University of Toronto and Cognitive & Movement Disorders Neurologist, Sunnybrook Health Sciences Centre
Very happy to share our article just published in Brain. Well done Dr. Saira Mirza and Maurice Pasternak. @GENFI1 @Sunnybrook @UofT_DoM @UofTNeurology : Disease-modifying effects of TMEM106B in genetic frontotemporal dementia: a longitudinal GENFI study academic.oup.com/brain/article/…
Please re-Tweet to raise awareness: When people with #dementia forget, we can help them remember. (image: @tonyhusband1) #Alzheimers #kindness
Excellent opportunity!!
🧠 We’re hiring 🧠 Join our growing Brain Medicine Program as a Research and Evaluation Lead! Drive integration of brain specialties, health systems and evaluative science research and QI initiatives. Help the future of brain medicine! Apply 👇 linkedin.com/jobs/view/4122…
Thanks to @CIHR_IA for this wonderful opportunity to contribute to aging research in Canada.
🎉Welcome @MarioMasellis to the CIHR Institute of Aging Advisory Board! An expert in dementia and clinical neuroscience, his leadership in genomic and neurodegenerative research will help advance aging research.
So very proud of Maurice Pasternak for winning this prestigious award named in honour of Prof. Sandra Black, my mentor for so many years and my former PhD supervisor.
We're excited to announce Maurice Pasternak, PhD candidate at @UofTIMS, as the recipient of the 2024 Sandra E. Black Award in Clinical #DementiaResearch! His project at @Sunnybrook explores how genetic factors impact brain blood flow & connectivity in FTD bit.ly/3VkvNy4
So very proud of Maurice Pasternak for winning this prestigious award named in honour of Prof. Sandra Black, my mentor for so many years and my former PhD supervisor.
We're excited to announce Maurice Pasternak, PhD candidate at @UofTIMS, as the recipient of the 2024 Sandra E. Black Award in Clinical #DementiaResearch! His project at @Sunnybrook explores how genetic factors impact brain blood flow & connectivity in FTD bit.ly/3VkvNy4
Thanks to Gaby Rogers (@gabyrogers) from Channel 9 News (@Channel9) for covering our trial to help patients who have isolated Rapid Eye Movement Sleep Behaviour Disorder the greatest risk factor for Parkinson’s or Dementia with Lewy Bodies profsimonlewis.com/c9-irbd-trial-… @Macquarie_Uni
Well done Anthaea-Grace 👏👏 doi.org/10.1016/j.park…
Excited to share with you our letter considering the importance of APOE E4 allele evaluation in the etiology of small vessel disease in sporadic AD. @Sunnybrook @UofT_DoM @UofTNeurology jamanetwork.com/journals/jaman…
Excited to share with you our new paper led by Dr. Erlan Sanchez examining the association between plasma biomarkers and cognitive performance between and across neurodegenerative and cerebrovascular diseases: alz-journals.onlinelibrary.wiley.com/share/EVUNBRWM…
A very exciting @NextGenDlb webinar is coming up on November 17 and 18! Get to know the future leaders in the field and what they are doing to move the field forward. Register at: nextgendlb.com
Excited to be presenting on ' From Lewy bodies to tauopathies: The spectrum of dementia-parkinsonism' at the upcoming @11thCCD in Toronto at the Sheraton Centre Hotel - Nov 2 to 4, 2023!
I'm very excited to share this paper on normative values for the Multiple Sleep Latency Test (a daytime #sleep test) - many thanks to Andrew Iskander, Trevor Jairam, @ChristineWang33 @brianjamesmurra ! @Sunnybrook @UofTNeurology @uoftmedicine @UofTIMS authors.elsevier.com/a/1hOmc4y2Nr4v…
What we know so far in Parkinson and Lewy Body Dementia in one slide from amazing Sonja Scholz @NINDSnews rocks it today @WorldPDCongress plenary. The genetics are different however, overlap quite a bit. Complicated and important to sort this out.
Have we been underestimating the value of cholinesterase inhibitors (ChEIs) in #Parkinsons? Check out left shift on this table favoring ChEIs over placebo! New meta-analysis suggests associated with improvement of individual neuropsychiatric symptoms, specifically delusions and…